Inhaler treatment for lung cancer
Links shared publicly online about this topic.
- 0total visits
Inhaler treatment for lung cancer
View full resource at medicalxpress.com
Tags: Cancer, Lung Cancer, Lung
Most Recently Shared on October 11, 2011 at 4:46 pm By:
Inhaler treatment for lung cancer: Lung cancer patients could receive safer and more efficient treatment through... http://t.co/BZzlM0or
Also Shared By:
Scientists aim to kill lung tumors
labspaces.net — “Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development.” View full resource at labspaces.net
Most Recently Shared on May 5, 2012 at 3:30 pm By:
Scientists aim to kill lung tumors - http://t.co/zGkxznf0
PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue
news-medical.net — “Lung cancer is the leading cause of cancer death throughout the world. Standard treatment methods do not usually result in long-term recovery. In addition to the proliferation of the tumour cells, the growth of blood vessels controls tumors development. The blood vessel growth is controlled by several signalling molecules. Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Justus Liebig University Giessen have discovered a molecule that plays a key role in th” View full resource at news-medical.net
Most Recently Shared on May 5, 2012 at 12:37 pm By:
News-Medical.Net Health News and Oncology
Oncology News: PDE4 enzyme regulates division of tumour cells and blood vessel growth in cancer tissue: Lung can... http://t.co/2fLg0VAG
State of health, not age, should decide treatment for cancer
news-medical.net — “In a study of patients 65 and older with non-small-cell lung cancer (NSCLC), younger patients were more likely to receive treatment than older patients, regardless of overall health and prognosis.” View full resource at news-medical.net
Most Recently Shared on May 3, 2012 at 1:28 pm By:
Lung Cancer News: State of health, not age, should decide treatment for cancer: In a study of patients 65 and ol... http://t.co/SezljvJ3
Possible new cancer treatment identified
sciencedaily.com — “New research findings show how it may be possible to render cancer tumors harmless without affecting the other cells and tissues in the body. The findings apply to cancers including breast, lung and bowel cancer. Many of the most common chemotherapy drugs used to treat cancer have serious side effects because they not only affect the cells in the cancer tumor, but also the cells in the rest of the body.” View full resource at sciencedaily.com
Most Recently Shared on April 25, 2012 at 7:32 pm By:
Potential New Cancer Treatment Identified http://t.co/HyPp2pqF
Mesothelioma: Promising Developments In Early Diagnosis And Treatment
medicalnewstoday.com — “New results presented at 3rd European Lung Cancer Conference in Geneva, Switzerland show important steps being made to improve the diagnosis and treatment of malignant pleural mesothelioma, an agg” View full resource at medicalnewstoday.com
Most Recently Shared on April 19, 2012 at 8:05 am By:
Mesothelioma: Promising Developments In Early Diagnosis And Treatment http://t.co/YpcFwIvZ #asbestos #mesothelioma
Idera commences IMO-3100 Phase 2 clinical trial for psoriasis
news-medical.net — “Idera Pharmaceuticals, Inc. today announced the treatment of the first patient in a Phase 2 clinical trial of IMO-3100, the Company's lead Toll-like receptor (TLR) inhibitor for the treatment of autoimmune diseases, in patients with moderate to severe plaque psoriasis.” View full resource at news-medical.net
Most Recently Shared on April 18, 2012 at 6:26 am By:
Idera commences IMO-3100 Phase 2 clinical trial for psoriasis: Idera Pharmaceuticals, Inc. today announced the t... http://t.co/wEfJcG0T
Mayo Clinic experts available to discuss mental health challenges faced by cancer survivors
news-medical.net — “April is National Cancer Control Month, which focuses on the prevention, detection, and treatment of cancer and on efforts to improve the quality of life of the more than 11 million cancer survivors in the United States.” View full resource at news-medical.net
Most Recently Shared on April 12, 2012 at 11:57 am By:
Lung Cancer News: Mayo Clinic experts available to discuss mental health challenges faced by cancer survivors: A... http://t.co/s9xYpxLl
Majority of Michigan oncology practices follow treatment guidelines for common cancers
news-medical.net — “A majority of Michigan oncology practices participating in a statewide consortium followed treatment guidelines for common cancers, but had gaps in managing symptoms and end-of-life care, according to a new study.” View full resource at news-medical.net
Most Recently Shared on April 11, 2012 at 7:10 am By:
Breast Cancer News: Majority of Michigan oncology practices follow treatment guidelines for common cancers: A ma... http://t.co/ANozn5SF
Opportunity for developers and marketers of EGFR inhibitors in Brazil and Mexico
news-medical.net — “Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that patient access to premium-priced targeted cancer treatments in Brazil and Mexico is improving, creating an opportunity for developers and marketers of epidermal growth factor receptor (EGFR) inhibitors.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 2:18 pm By:
Breast Cancer News: Opportunity for developers and marketers of EGFR inhibitors in Brazil and Mexico: Decision R... http://t.co/GzA99dJb
Study assesses link between antifolate medications, KRAS mutations and amplification
news-medical.net — “Testing patients with non-small cell lung cancer for both mutations and amplifications of the KRAS gene prior to therapy may help to predict response to treatment with antifolates, according to the updated results of a preclinical study presented at the AACR Annual Meeting 2012, held here March 31 - April 4.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:29 am By:
Lung Cancer News: Study assesses link between antifolate medications, KRAS mutations and amplification: Testing ... http://t.co/pTIigUcV
Combination treatment shows promise against NSCLC patients ineligible for bevacizumab
news-medical.net — “A combination of nab-paclitaxel and carboplatin for the treatment of non-small cell lung cancer may be a promising option for patients ineligible for treatment with bevacizumab, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.” View full resource at news-medical.net
Most Recently Shared on April 4, 2012 at 11:27 am By:
Lung Cancer News: Combination treatment shows promise against NSCLC patients ineligible for bevacizumab: A combi... http://t.co/vU5W9EYs
Oncologists may not detect patient-caregiver conflict, study finds - Related Stories - Hospice and Palliative Medicine SmartBrief
smartbrief.com — “A study showed oncologists often are not aware of disagreements between patients and their caregivers over treatments such as tests or hospice care, Virginia Commonwealth University researchers reported in the journal Lung Cancer. Researcher Laura Siminoff said oncologists usually do not explore th…” View full resource at smartbrief.com
Most Recently Shared on March 30, 2012 at 4:21 pm By:
Oncologists may not detect patient-caregiver conflict, study finds http://t.co/TzQTpbLv #hpm
Cancer docs often don't notice family discord | Reuters
reuters.com — “NEW YORK (Reuters Health) - Doctors caring for lung cancer patients are often unaware when patients and their caregivers disagree about the best course of treatment, according to a new study.Unless you're” View full resource at reuters.com
Most Recently Shared on March 28, 2012 at 8:51 pm By:
Cancer docs often don't notice family discord http://t.co/vQ7GMlVD
Clovis Oncology Announces Enrollment of First Patient in First Human Study of Oral EGFR Mutant-Selective Inhibitor CO-1686 - Yahoo! News
news.yahoo.com — “From Yahoo! News: Clovis Oncology, Inc. (Nasdaq: CLVS) announced today that the first clinical study of CO-1686 has commenced with the dosing of the first patient at a U.S. study site. CO-1686 is a novel, oral, targeted covalent inhibitor of epidermal growth factor receptor (EGFR) mutations currently being studied for the treatment of non-small cell lung cancer (NSCLC).” View full resource at news.yahoo.com
Most Recently Shared on March 28, 2012 at 11:04 am By:
Clovis Oncology Announces Enrollment of First Patient in First Human Study of Oral EGFR Mutant-Selective Inhibit... http://t.co/48JzhFAO
Major Lung Cancer Screening Trial announced by the NHS in Scotland Using... -- DESOTO, Kan., March 22, 2012 /PRNewswire/ --
prnewswire.com — “Major Lung Cancer Screening Trial announced by the NHS in Scotland Using an Innovative Blood Test, EarlyCDT(R) -- Lung. Efforts to enable the early detection of lung cancer when treatment options are most successful to begin fourth quarter 2012.” View full resource at prnewswire.com
Most Recently Shared on March 26, 2012 at 5:42 am By:
Peter Beck Kim Doctor, Family Medicine Doctor, and Physician
Scotland to do lung CA detection trial with a blood test followed by CT. Why is this is news on this side of the pond? http://t.co/6rIwIpMB
Advertisement
FightCancer
@FightCancer
Inhaler treatment for lung cancer http://t.co/aTg8lrOT
1 year ago...